Targeting the tumor stroma for cancer therapy

M Xu, T Zhang, R **a, Y Wei, X Wei - Molecular Cancer, 2022‏ - Springer
Tumors are comprised of both cancer cells and surrounding stromal components. As an
essential part of the tumor microenvironment, the tumor stroma is highly dynamic …

Challenges and advances in clinical applications of mesenchymal stromal cells

T Zhou, Z Yuan, J Weng, D Pei, X Du, C He… - Journal of hematology & …, 2021‏ - Springer
Mesenchymal stromal cells (MSCs), also known as mesenchymal stem cells, have been
intensely investigated for clinical applications within the last decades. However, the majority …

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

YR Li, Y Fang, Z Lyu, Y Zhu, L Yang - Journal of Translational Medicine, 2023‏ - Springer
Cancer stem cells (CSCs) have emerged as key contributors to tumor initiation, growth, and
metastasis. In addition, CSCs play a significant role in inducing immune evasion, thereby …

Current and future immunotherapeutic approaches in pancreatic cancer treatment

P Farhangnia, H Khorramdelazad, H Nickho… - Journal of Hematology & …, 2024‏ - Springer
Pancreatic cancer is a major cause of cancer-related death, but despondently, the outlook
and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it …

Epithelial and stromal co-evolution and complicity in pancreatic cancer

SR Hingorani - Nature Reviews Cancer, 2023‏ - nature.com
Pancreatic ductal adenocarcinomas are distinguished by their robust desmoplasia, or
fibroinflammatory response. Dominated by non-malignant cells, the mutated epithelium must …

Novel strategies for cancer immunotherapy: counter-immunoediting therapy

S Liu, Q Sun, X Ren - Journal of Hematology & Oncology, 2023‏ - Springer
The advent of immunotherapy has made an indelible mark on the field of cancer therapy,
especially the application of immune checkpoint inhibitors in clinical practice. Although …

The LIN28/let-7 pathway in cancer

J Balzeau, MR Menezes, S Cao, JP Hagan - Frontiers in genetics, 2017‏ - frontiersin.org
Among all tumor suppressor microRNAs, reduced let-7 expression occurs most frequently in
cancer and typically correlates with poor prognosis. Activation of either LIN28A or LIN28B …

The role of stromal cancer-associated fibroblasts in pancreatic cancer

D Von Ahrens, TD Bhagat, D Nagrath, A Maitra… - Journal of hematology & …, 2017‏ - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer generally refractory to
conventional treatments. Cancer-associated fibroblasts (CAFs) are cellular components of …

Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets

Y Shi, L Du, L Lin, Y Wang - Nature reviews Drug discovery, 2017‏ - nature.com
Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), exist in many
tissues and are known to actively migrate to sites of tissue injury, where they participate in …

[HTML][HTML] Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells

C Melzer, V Rehn, Y Yang, H Bähre, J von der Ohe… - Cancers, 2019‏ - mdpi.com
MSC-derived exosomes display, among others, an efficient biocompatibility and a reduced
intrinsic immunogenicity, representing a valuable vehicle for drug delivery in a tumor …